For: | Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Strategy for treatment of nonerosive reflux disease in Asia. World J Gastroenterol 2008; 14(20): 3123-3128 [PMID: 18506915 DOI: 10.3748/wjg.14.3123] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i20/3123.htm |
Number | Citing Articles |
1 |
Kazunari Tominaga, Mototsugu Kato, Hiroshi Takeda, Yasuyuki Shimoyama, Eiji Umegaki, Ryuichi Iwakiri, Kenji Furuta, Koichi Sakurai, Takeo Odaka, Hiroaki Kusunoki, Akihito Nagahara, Katsuhiko Iwakiri, Takahisa Furuta, Kazunari Murakami, Hiroto Miwa, Yoshikazu Kinoshita, Ken Haruma, Shin’ichi Takahashi, Sumio Watanabe, Kazuhide Higuchi, Motoyasu Kusano, Kazuma Fujimoto, Tetsuo Arakawa. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. Journal of Gastroenterology 2014; 49(10): 1392 doi: 10.1007/s00535-013-0896-9
|
2 |
WM Simmonds. Nonerosive reflux disease as a presentation of gastro-oesophageal reflux disease. South African Family Practice 2011; 53(4): 326 doi: 10.1080/20786204.2011.10874108
|
3 |
F.M. Huerta-Iga, J.L. Tamayo-de la Cuesta, A. Noble-Lugo, J.M. Remes-Troche, M.A. Valdovinos-Díaz, R.I. Carmona-Sánchez. Consenso mexicano de enfermedad por relujo gastroesofágico. Parte I. Revista de Gastroenterología de México 2012; 77(4): 193 doi: 10.1016/j.rgmx.2012.10.002
|
4 |
Toru Hiyama, Masaharu Yoshihara, Shinji Tanaka, Ken Haruma, Kazuaki Chayama. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract. Journal of Gastroenterology and Hepatology 2009; 24(4): 537 doi: 10.1111/j.1440-1746.2009.05780.x
|
5 |
Yurika Kimura, Mutsumi Sugiura, Tomofumi Kato, Nao Makino, Yukio Ohmae, Seiji Kishimoto. Value of Barium Swallow Studies in Predicting the Response to Rabeprazole in Elderly Patients with Laryngopharyngeal Reflux Disease and Nonerosive Reflux Disease in Particular. Annals of Otology, Rhinology & Laryngology 2010; 119(9): 631 doi: 10.1177/000348941011900911
|
6 |
Toru Hiyama, Keitaro Matsuo, Yuji Urabe, Tatsuma Fukuhara, Shinji Tanaka, Masaharu Yoshihara, Ken Haruma, Kazuaki Chayama. Meta‐analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non‐erosive reflux disease. Journal of Gastroenterology and Hepatology 2009; 24(8): 1326 doi: 10.1111/j.1440-1746.2009.05879.x
|
7 |
KY Marakhouski, GA Karaseva, DN Ulasivich, Y Kh Marakhouski. Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease. Clinical Medicine Insights: Gastroenterology 2017; 10: 117955221770945 doi: 10.1177/1179552217709456
|
8 |
Yukie Kohata, Yasuhiro Fujiwara, Hirohisa Machida, Hirotoshi Okazaki, Hirokazu Yamagami, Tetsuya Tanigawa, Kenji Watanabe, Toshio Watanabe, Kazunari Tominaga, Tetsuo Arakawa. Pathogenesis of proton‐pump inhibitor‐refractory non‐erosive reflux disease according to multichannel intraluminal impedance‐pH monitoring. Journal of Gastroenterology and Hepatology 2012; 27(s3): 58 doi: 10.1111/j.1440-1746.2012.07074.x
|
9 |
Pin‐Chao Wang, Ching‐Sheng Hsu, Tai‐Chung Tseng, Tsung‐Cheng Hsieh, Chien‐Hwa Chen, Wei‐Chih Su, Hans Hsienhong Lin, Chia‐Chi Wang. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis. Journal of Gastroenterology and Hepatology 2012; 27(3): 586 doi: 10.1111/j.1440-1746.2011.06881.x
|
10 |
Jiao Xiao, Yunfeng Yang, Yuanrong Zhu, Yan Qin, Yifan Li, Mengjie Fu, Zhengdong Zhai, Lingyun Zhu, Jenny M. Wilkinson. Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta‐Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/1505394
|
11 |
Hye Kyung Jeon, Gwang Ha Kim, Moon Won Lee, Dong Chan Joo, Bong Eun Lee. Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease. Journal of Clinical Medicine 2022; 11(7): 1965 doi: 10.3390/jcm11071965
|
12 |
Kenji Koshino, Kyoichi Adachi, Kenji Furuta, Shunji Ohara, Terumi Morita, Shuji Nakata, Takashi Tanimura, Masaharu Miki, Yoshikazu Kinoshita. Effects of mosapride on esophageal functions and gastroesophageal reflux. Journal of Gastroenterology and Hepatology 2010; 25(6): 1066 doi: 10.1111/j.1440-1746.2010.06280.x
|
13 |
Chihiro Minatsuki, Nobutake Yamamichi, Takeshi Shimamoto, Hikaru Kakimoto, Yu Takahashi, Mitsuhiro Fujishiro, Yoshiki Sakaguchi, Chiemi Nakayama, Maki Konno-Shimizu, Rie Matsuda, Satoshi Mochizuki, Itsuko Asada-Hirayama, Yosuke Tsuji, Shinya Kodashima, Satoshi Ono, Keiko Niimi, Toru Mitsushima, Kazuhiko Koike, Masaru Katoh. Background Factors of Reflux Esophagitis and Non-Erosive Reflux Disease: A Cross-Sectional Study of 10,837 Subjects in Japan. PLoS ONE 2013; 8(7): e69891 doi: 10.1371/journal.pone.0069891
|
14 |
Hiroto Miwa, Tadayuki Oshima, Toshihiko Tomita, Yongmin Kim, Kazutoshi Hori, Takayuki Matsumoto. Gastro-esophageal reflux disease: the recent trend in Japan. Clinical Journal of Gastroenterology 2008; 1(4): 133 doi: 10.1007/s12328-008-0039-7
|
15 |
Masaki Miyamoto, Noriaki Manabe, Ken Haruma. Efficacy of the Addition of Prokinetics for Proton Pump Inhibitor (PPI) Resistant Non-erosive Reflux Disease (NERD) Patients: Significance of Frequency Scale for the Symptom of GERD (FSSG) on Decision of Treatment Strategy. Internal Medicine 2010; 49(15): 1469 doi: 10.2169/internalmedicine.49.3615
|
16 |
Kazunari Tominaga, Tetsuo Arakawa. Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract. Frontiers in Pharmacology 2015; 6 doi: 10.3389/fphar.2015.00007
|
17 |
Terumi Morita, Kenji Furuta, Kyoichi Adachi, Shunji Ohara, Takashi Tanimura, Kenji Koshino, Tomochika Uemura, Kohji Naora, Yoshikazu Kinoshita. Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux. Journal of Neurogastroenterology and Motility 2012; 18(2): 181 doi: 10.5056/jnm.2012.18.2.181
|
18 |
T. Kondo, T. Oshima, J. Koseki, T. Hattori, Y. Kase, T. Tomita, H. Fukui, J. Watari, H. Miwa. Effect of Rikkunshito on the expression of substance P and CGRP in dorsal root ganglion neurons and voluntary movement in rats with experimental reflux esophagitis. Neurogastroenterology & Motility 2014; 26(7): 913 doi: 10.1111/nmo.12342
|
19 |
Yutaka Yamaji, Yoshihiro Isomura, Shuntaro Yoshida, Atsuo Yamada, Yoshihiro Hirata, Kazuhiko Koike. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease. Journal of Digestive Diseases 2014; 15(9): 469 doi: 10.1111/1751-2980.12167
|
20 |
Akira Mizuki, Masayuki Tatemichi, Terue Sakakibara, Yukihiko Miura, Shigeyuki Zeki, Mitsuru Ohata, Kenji Matsuo, Fumio Kawamura, Hiroshi Nagata. A Multicenter, Randomized, Open-Label Trial: Efficacy of Once-Daily Versus Twice-Daily Double-Dose Rabeprazole on Refractory Gastroesophageal Reflux Disease-Related Symptoms and Quality of Life. Current Therapeutic Research 2016; 79: 1 doi: 10.1016/j.curtheres.2016.11.002
|
21 |
Yasuhiro NISHIZAKI, Toru HIGASHI, Riko ICHIKAWA, Jun AOKI, Hirokazu SHIOZAWA, Tetsuhei OGAWA, Tetsuya MINE, Norihito WATANABE. Aging related symptoms, disease and cancer in digestive system: A reference for better performance to health evaluation and promotion. Health Evaluation and Promotion 2011; 38(4): 547 doi: 10.7143/jhep.38.547
|
22 |
Yuguo Dong, Lin Dong, Xiaoli Gu, Yanqin Wang, Yuhe Liao, Rafael Luque, Zupeng Chen. Sustainable production of active pharmaceutical ingredients from lignin-based benzoic acid derivatives via “demand orientation”. Green Chemistry 2023; 25(10): 3791 doi: 10.1039/D3GC00241A
|
23 |
Hiroto Miwa, Junichi Koseki, Tadayuki Oshima, Takashi Kondo, Toshihiko Tomita, Jiro Watari, Takayuki Matsumoto, Tomohisa Hattori, Kunitsugu Kubota, Seiichi Iizuka. Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. Journal of Gastroenterology 2010; 45(5): 478 doi: 10.1007/s00535-009-0180-1
|
24 |
Na Rae Ha, Hang Lak Lee, Oh Young Lee, Byung Chul Yoon, Ho Soon Choi, Joon Soo Hahm, You Hern Ahn, Dong Hee Koh. Differences in Clinical Characteristics between Patients with Non-Erosive Reflux Disease and Erosive Esophagitis in Korea. Journal of Korean Medical Science 2010; 25(9): 1318 doi: 10.3346/jkms.2010.25.9.1318
|
25 |
Risa Uemura, Yoshiki Murakami, Atsushi Hashimoto, Akinari Sawada, Koji Otani, Koichi Taira, Shuhei Hosomi, Yasuaki Nagami, Fumio Tanaka, Noriko Kamata, Hirokazu Yamagami, Tetsuya Tanigawa, Toshio Watanabe, Y-h Taguchi, Yasuhiro Fujiwara. Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis. International Journal of Molecular Sciences 2017; 18(8): 1611 doi: 10.3390/ijms18081611
|
26 |
Yasuhisa Sakata, Kazunari Tominaga, Mototsugu Kato, Hiroshi Takeda, Yasuyuki Shimoyama, Toshihisa Takeuchi, Ryuichi Iwakiri, Kenji Furuta, Kouichi Sakurai, Takeo Odaka, Hiroaki Kusunoki, Akihito Nagahara, Katsuhiko Iwakiri, Takahisa Furuta, Kazunari Murakami, Hiroto Miwa, Yoshikazu Kinoshita, Ken Haruma, Shin’ichi Takahashi, Sumio Watanabe, Kazuhide Higuchi, Kazuma Fujimoto, Motoyasu Kusano, Tetsuo Arakawa. Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-116
|
27 |
Yukie Kohata, Yasuhiro Fujiwara, Hirokazu Yamagami, Tetsuya Tanigawa, Masatsugu Shiba, Kenji Watanabe, Toshio Watanabe, Kazunari Tominaga, Tetsuo Arakawa. Usefulness of baseline impedance in patients with proton pump inhibitor‐refractory nonerosive reflux disease. Journal of Gastroenterology and Hepatology 2015; 30(S1): 36 doi: 10.1111/jgh.12743
|
28 |
Xiao-Jun Yang, Hong-Mei Jiang, Xiao-Hua Hou, Jun Song. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World Journal of Gastroenterology 2015; 21(14): 4302-4309 doi: 10.3748/wjg.v21.i14.4302
|
29 |
Junzo Kamei, Shunsuke Hayashi, Akane Sakai, Yuki Nakanishi, Misa Kai, Megumi Ikegami, Hiroko Ikeda, Thiago Mattar Cunha. Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NFκB) phosphorylation in spinal cord of mice. PLOS ONE 2017; 12(2): e0171819 doi: 10.1371/journal.pone.0171819
|
30 |
Kazunari Tominaga, Ryuichi Iwakiri, Kazuma Fujimoto, Yasuhiro Fujiwara, Mio Tanaka, Yasuyuki Shimoyama, Eiji Umegaki, Kazuhide Higuchi, Motoyasu Kusano, Tetsuo Arakawa. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. Journal of Gastroenterology 2012; 47(3): 284 doi: 10.1007/s00535-011-0488-5
|
31 |
Mosaburo Kainuma, Yoshihiro Imazu, Hiroki Imazu, Koichiro Tanaka, Yasuhito Uezono, Kazunari Tominaga, Makoto Fujimoto. A review of frequently used Kampo prescriptions. Part 5. Rikkunshito. Traditional & Kampo Medicine 2024; 11(2): 89 doi: 10.1002/tkm2.1414
|
32 |
Kazunari Tominaga, Tetsuo Arakawa. Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application. Journal of Gastroenterology 2013; 48(4): 452 doi: 10.1007/s00535-013-0788-z
|
33 |
Halil Haldun Emiroglu, Semra Sokucu, Ozlem Durmaz Suoglu, Mine Gulluoglu, Selim Gokce. Is there a relationship between Helicobacter pylori infection and erosive reflux disease in children?. Acta Paediatrica 2010; 99(1): 121 doi: 10.1111/j.1651-2227.2009.01512.x
|
34 |
Min-Kuei Tsai, Hueisch-Jy Ding, Hsueh-Chou Lai, Kuo-Yang Yen, Chia-Ing Li, Yu-Yi Lin, Kai-Yuan Cheng, Keh-Bin Wang, Chia-Hung Kao. Detection of Gastroesophageal Reflux Esophagitis Using 2-fluoro-2-deoxy-d-glucose Positron Emission Tomography. The Scientific World Journal 2012; 2012: 1 doi: 10.1100/2012/702803
|